Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.

BACKGROUND:<br>Since screening programs identify only a small proportion of the population as eligible for an intervention, genomic prediction of heritable risk factors could decrease the number needing to be screened by removing individuals at low genetic risk. We therefore tested whether a p...

Full description

Bibliographic Details
Main Authors: Forgetta, V, Forest, M, Durand, A, Bhatnagar, S, Kemp, JP, Nethander, M, Evans, D, Morris, JA, Kiel, DP, Rivadeneira, F, Johansson, H, Harvey, NC, Mellström, D, Karlsson, M, Cooper, C, Evans, DM, Keller-Baruch, J, Clarke, R, Kanis, JA, Orwoll, E, McCloskey, EV, Ohlsson, C, Pineau, J, Leslie, WD, Greenwood, CMT, Richards, JB
Format: Journal article
Language:English
Published: Public Library of Science 2020
_version_ 1797083061661204480
author Forgetta, V
Forest, M
Durand, A
Bhatnagar, S
Kemp, JP
Nethander, M
Evans, D
Morris, JA
Kiel, DP
Rivadeneira, F
Johansson, H
Harvey, NC
Mellström, D
Karlsson, M
Cooper, C
Evans, DM
Keller-Baruch, J
Clarke, R
Kanis, JA
Orwoll, E
McCloskey, EV
Ohlsson, C
Pineau, J
Leslie, WD
Greenwood, CMT
Richards, JB
author_facet Forgetta, V
Forest, M
Durand, A
Bhatnagar, S
Kemp, JP
Nethander, M
Evans, D
Morris, JA
Kiel, DP
Rivadeneira, F
Johansson, H
Harvey, NC
Mellström, D
Karlsson, M
Cooper, C
Evans, DM
Keller-Baruch, J
Clarke, R
Kanis, JA
Orwoll, E
McCloskey, EV
Ohlsson, C
Pineau, J
Leslie, WD
Greenwood, CMT
Richards, JB
author_sort Forgetta, V
collection OXFORD
description BACKGROUND:<br>Since screening programs identify only a small proportion of the population as eligible for an intervention, genomic prediction of heritable risk factors could decrease the number needing to be screened by removing individuals at low genetic risk. We therefore tested whether a polygenic risk score for heel quantitative ultrasound speed of sound (SOS)-a heritable risk factor for osteoporotic fracture-can identify low-risk individuals who can safely be excluded from a fracture risk screening program. <br><br>METHODS AND FINDINGS:<br>A polygenic risk score for SOS was trained and selected in 2 separate subsets of UK Biobank (comprising 341,449 and 5,335 individuals). The top-performing prediction model was termed "gSOS", and its utility in fracture risk screening was tested in 5 validation cohorts using the National Osteoporosis Guideline Group clinical guidelines (N = 10,522 eligible participants). All individuals were genome-wide genotyped and had measured fracture risk factors. Across the 5 cohorts, the average age ranged from 57 to 75 years, and 54% of studied individuals were women. The main outcomes were the sensitivity and specificity to correctly identify individuals requiring treatment with and without genetic prescreening. The reference standard was a bone mineral density (BMD)-based Fracture Risk Assessment Tool (FRAX) score. The secondary outcomes were the proportions of the screened population requiring clinical-risk-factor-based FRAX (CRF-FRAX) screening and BMD-based FRAX (BMD-FRAX) screening. gSOS was strongly correlated with measured SOS (r2 = 23.2%, 95% CI 22.7% to 23.7%). Without genetic prescreening, guideline recommendations achieved a sensitivity and specificity for correct treatment assignment of 99.6% and 97.1%, respectively, in the validation cohorts. However, 81% of the population required CRF-FRAX tests, and 37% required BMD-FRAX tests to achieve this accuracy. Using gSOS in prescreening and limiting further assessment to those with a low gSOS resulted in small changes to the sensitivity and specificity (93.4% and 98.5%, respectively), but the proportions of individuals requiring CRF-FRAX tests and BMD-FRAX tests were reduced by 37% and 41%, respectively. Study limitations include a reliance on cohorts of predominantly European ethnicity and use of a proxy of fracture risk. <br><br>CONCLUSIONS:<br>Our results suggest that the use of a polygenic risk score in fracture risk screening could decrease the number of individuals requiring screening tests, including BMD measurement, while maintaining a high sensitivity and specificity to identify individuals who should be recommended an intervention.
first_indexed 2024-03-07T01:36:38Z
format Journal article
id oxford-uuid:956b17e8-e013-4914-8c85-a5d554f71b2a
institution University of Oxford
language English
last_indexed 2024-03-07T01:36:38Z
publishDate 2020
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:956b17e8-e013-4914-8c85-a5d554f71b2a2022-03-26T23:46:15ZDevelopment of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:956b17e8-e013-4914-8c85-a5d554f71b2aEnglishSymplectic ElementsPublic Library of Science2020Forgetta, VForest, MDurand, ABhatnagar, SKemp, JPNethander, MEvans, DMorris, JAKiel, DPRivadeneira, FJohansson, HHarvey, NCMellström, DKarlsson, MCooper, CEvans, DMKeller-Baruch, JClarke, RKanis, JAOrwoll, EMcCloskey, EVOhlsson, CPineau, JLeslie, WDGreenwood, CMTRichards, JBBACKGROUND:<br>Since screening programs identify only a small proportion of the population as eligible for an intervention, genomic prediction of heritable risk factors could decrease the number needing to be screened by removing individuals at low genetic risk. We therefore tested whether a polygenic risk score for heel quantitative ultrasound speed of sound (SOS)-a heritable risk factor for osteoporotic fracture-can identify low-risk individuals who can safely be excluded from a fracture risk screening program. <br><br>METHODS AND FINDINGS:<br>A polygenic risk score for SOS was trained and selected in 2 separate subsets of UK Biobank (comprising 341,449 and 5,335 individuals). The top-performing prediction model was termed "gSOS", and its utility in fracture risk screening was tested in 5 validation cohorts using the National Osteoporosis Guideline Group clinical guidelines (N = 10,522 eligible participants). All individuals were genome-wide genotyped and had measured fracture risk factors. Across the 5 cohorts, the average age ranged from 57 to 75 years, and 54% of studied individuals were women. The main outcomes were the sensitivity and specificity to correctly identify individuals requiring treatment with and without genetic prescreening. The reference standard was a bone mineral density (BMD)-based Fracture Risk Assessment Tool (FRAX) score. The secondary outcomes were the proportions of the screened population requiring clinical-risk-factor-based FRAX (CRF-FRAX) screening and BMD-based FRAX (BMD-FRAX) screening. gSOS was strongly correlated with measured SOS (r2 = 23.2%, 95% CI 22.7% to 23.7%). Without genetic prescreening, guideline recommendations achieved a sensitivity and specificity for correct treatment assignment of 99.6% and 97.1%, respectively, in the validation cohorts. However, 81% of the population required CRF-FRAX tests, and 37% required BMD-FRAX tests to achieve this accuracy. Using gSOS in prescreening and limiting further assessment to those with a low gSOS resulted in small changes to the sensitivity and specificity (93.4% and 98.5%, respectively), but the proportions of individuals requiring CRF-FRAX tests and BMD-FRAX tests were reduced by 37% and 41%, respectively. Study limitations include a reliance on cohorts of predominantly European ethnicity and use of a proxy of fracture risk. <br><br>CONCLUSIONS:<br>Our results suggest that the use of a polygenic risk score in fracture risk screening could decrease the number of individuals requiring screening tests, including BMD measurement, while maintaining a high sensitivity and specificity to identify individuals who should be recommended an intervention.
spellingShingle Forgetta, V
Forest, M
Durand, A
Bhatnagar, S
Kemp, JP
Nethander, M
Evans, D
Morris, JA
Kiel, DP
Rivadeneira, F
Johansson, H
Harvey, NC
Mellström, D
Karlsson, M
Cooper, C
Evans, DM
Keller-Baruch, J
Clarke, R
Kanis, JA
Orwoll, E
McCloskey, EV
Ohlsson, C
Pineau, J
Leslie, WD
Greenwood, CMT
Richards, JB
Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.
title Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.
title_full Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.
title_fullStr Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.
title_full_unstemmed Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.
title_short Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study.
title_sort development of a polygenic risk score to improve screening for fracture risk a genetic risk prediction study
work_keys_str_mv AT forgettav developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT forestm developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT duranda developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT bhatnagars developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT kempjp developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT nethanderm developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT evansd developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT morrisja developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT kieldp developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT rivadeneiraf developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT johanssonh developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT harveync developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT mellstromd developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT karlssonm developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT cooperc developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT evansdm developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT kellerbaruchj developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT clarker developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT kanisja developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT orwolle developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT mccloskeyev developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT ohlssonc developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT pineauj developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT lesliewd developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT greenwoodcmt developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy
AT richardsjb developmentofapolygenicriskscoretoimprovescreeningforfractureriskageneticriskpredictionstudy